Molecules · 2012 · 48 citations · 25 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyStructure-activity RelationshipsCholinergic PharmacologyEnzyme InhibitionLigand BindingPotency OptimizationStructure-activity Relationship AnalysisAcetylcholinesterase InhibitorsAche InhibitionEnzyme Inhibition ScreeningEnzyme Inhibitor DiscoveryInhibitor ScreeningMedicinal Chemistry ApplicationsMolecular Docking Of InhibitorsProtein-ligand Complexes
(E)-2-(benzo[d]thiazol-2-yl)-3-heteroarylacrylonitriles are described as a new class of selective inhibitors of acetylcholinesterase (AChE). The most potent compound in the series exhibited good AChE inhibitory activity (IC₅₀ = 64 µM). Compound 7f was found to be more selective than galanthamine in inhibiting AChE and it showed a moderate selectivity index. Kinetic studies on AChE indicated that a competitive type of inhibition pattern exist for these acrylonitrile derivates. Molecular docking models of the ligand-AChE complexes suggest that compound 7 g is located on the periphery of the AChE active site.
25
A new and rapid colorimetric determination of acetylcholinesterase activity
George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.9K citations
Matthew Eldridge, Christopher W. Murray, T.R. Auton et al. · Journal of Computer-Aided Molecular Design · 1997 · 1.7K citations
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Paul B. Watkins · JAMA · 1994 · 787 citations